Canada · Health Canada Drug Product Database
APO-SUMATRIPTAN-NAPROXEN SODIUM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 107234
- DIN
- 02570165
- Form
- Tablet
- Company as listed by source
- APOTEX INC
- Source status
- Approved (2026-07-21)
- Source last updated
- 2026-09-01
Source-listed ingredients
- SUMATRIPTAN (SUMATRIPTAN SUCCINATE) — 85 MG
- NAPROXEN SODIUM — 500 MG
These values do not establish equivalence or a dose recommendation.
Packages
Package details are not available in this snapshot.
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →